[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$crdls
$CRDL surges XX% after positive news this morning. Database lock for Ph-2 pericarditis trial complete, with results in two weeks.
About $crdls
A biotech company.
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Month: XXXXXX +468,025%
1-Year High: XXXXXX on 2025-07-22
1-Year Low: X on 2025-06-05
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Month: X +400%
1-Year High: X on 2025-07-23
1-Year Low: X on 2025-05-08
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $crdls in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X +100%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-05-08
The most influential creators that mention $crdls in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Gantosj | X | XXXXXX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1-Year High: XXX% on 2025-07-23
1-Year Low: XXX% on 2025-07-23
Most Supportive Themes
- Positive Trial Results: (70%) Positive news regarding database lock and topline results for the Ph-2 pericarditis trial.
- Potential for Stock Re-rating: (30%) Discussion of the potential for rapid stock re-rating based on positive myocarditis data.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | X | X% |
| Total | XXX | XX% | XXX | XX% | X | X% |
Top topics mentioned In the posts about $crdls in the last XX hours
$crdl, $pcrx, united states, investment, $50b, robust
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Great move by $CRDL up XX% after the news this morning locking database from its Ph-2 pericarditis trail & topline results within X weeks"
@Gantosj on X 2025-07-22 16:11:42 UTC 13.3K followers, 2038 engagements
"📣 Biotech Stock News 07/22 @ Open $CRDL XX% Database Lock for Phase X Trial $CNTB XX% Appoints Industry Veteran to Board $STRO X% Research Collab. to Advance Standards $CGEM X% Acceptance of Abstracts for Zipalertinib $BIIB X% Highlighting Progress in Alzheimer's Disease $EHTH X% Achieves HITRUST i1 Certification $AZN X% Plans $50B investment in America $PCRX X% Strategic Collaboration to Expand Promotion $SRPT X% Voluntary Pause of ELEVIDYS Shipments $NAMS X% Presenting Alzheimer's Biomarker Data $DARE X% Webinar on DARE to PLAY Difference $OCUL X% Participation in Scientific Conferences"
@BiopharmIQ on X 2025-07-22 15:47:12 UTC 25.7K followers, 4716 engagements
"$CRDLs current valuation barely reflects the significant progress in its #pericarditis program which has already advanced to Ph-3. If the upcoming Ph-2 #myocarditis data turns out positive the stock could see a rapid re-rating to the upside. The Ph-3 trial for recurrent pericarditis is considered highly de-risked thanks to the robust results from the earlier open-label Ph-2 study which closely mirrors the approach used by an already approved IL-1 blocker"
@Gantosj on X 2025-07-22 13:53:13 UTC 13.3K followers, 3969 engagements
"So what we should look at from $CRDL's acute #myocarditis Ph-2 data The X primary outcome measures of the trial which were evaluated following XX weeks of double-blind therapy consist of cardiac MRI parameters: global longitudinal strain and extra-cellular volume which assess myocardial function and tissue characteristics associated with fibrosis and inflammation. Both parameters are recognized prognostic markers in patients with acute myocarditis"
@Gantosj on X 2025-07-22 12:58:26 UTC 13.3K followers, 8513 engagements